Exact Mass: 399.058
Exact Mass Matches: 399.058
Found 105 metabolites which its exact mass value is equals to given mass value 399.058,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Nocardicin E
(2R)-{(3S)-3-[(2Z)-2-(hydroxyimino)-2-(4-hydroxyphenyl)acetamido]-2-oxoazetidin-1-yl}(4-hydroxyphenyl)acetic acid
Timepidium bromide
Timepidium bromide anhydrous
A - Alimentary tract and metabolism > A03 - Drugs for functional gastrointestinal disorders > A03A - Drugs for functional gastrointestinal disorders > A03AB - Synthetic anticholinergics, quaternary ammonium compounds C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent ATC code: A03AB19
Vitisidin A
7-carboxy-4,11-dihydroxy-3-(4-hydroxy-3,5-dimethoxyphenyl)-2λ⁴,8-dioxatricyclo[7.3.1.0⁵,¹³]trideca-1(13),2,4,6,9,11-hexaen-2-ylium
Vitisidin A is a polyphenol compound found in foods of plant origin (PMID: 20428313). A polyphenol compound found in foods of plant origin (PhenolExplorer)
1H-Indole-2-carbonitrile, 4-(2-hydroxy-3-((1-methylethyl)amino)propoxy)-3-iodo-
1H-Indole-2-carbonitrile, 4-(2-hydroxy-3-((1-methylethyl)amino)propoxy)-3-iodo-
N6-Monobutyryl-cAMP
N-[9-(2,7-dihydroxy-2-oxo-4a,6,7,7a-tetrahydro-4H-furo[3,2-d][1,3,2]dioxaphosphinin-6-yl)purin-6-yl]butanamide
Pantoprazole Sulfone
6-(Difluoromethoxy)-2-[(3,4-dimethoxypyridin-2-yl)methanesulphonyl]-1H-1,3-benzodiazole
R-4'-phosphopantothenoyl-L-cysteine
2-[(3-{[2-hydroxy-3,3-dimethyl-1-oxido-4-(phosphonooxy)butylidene]amino}-1-oxidopropylidene)amino]-3-sulphanylpropanoic acid
R-4-phosphopantothenoyl-l-cysteine is a member of the class of compounds known as hybrid peptides. Hybrid peptides are compounds containing at least two different types of amino acids (alpha, beta, gamma, delta) linked to each other through a peptide bond. R-4-phosphopantothenoyl-l-cysteine is slightly soluble (in water) and a moderately acidic compound (based on its pKa). R-4-phosphopantothenoyl-l-cysteine can be found in a number of food items such as peach, chia, persian lime, and yellow pond-lily, which makes R-4-phosphopantothenoyl-l-cysteine a potential biomarker for the consumption of these food products.
3-Carbamoyl-acetyl-9-methyl-10-oxo-4,5,9-trihydroxy-9,10-dihydroanthracen-2-essigsaeure
3-Carbamoyl-acetyl-9-methyl-10-oxo-4,5,9-trihydroxy-9,10-dihydroanthracen-2-essigsaeure
7-[(2-Carboxy-1-pyrrolidinyl)methyl]-5,6-dihydroxy-2-methyl-4H-naphtho[2,3-b]pyran-4,8,9-trione
7-[(2-Carboxy-1-pyrrolidinyl)methyl]-5,6-dihydroxy-2-methyl-4H-naphtho[2,3-b]pyran-4,8,9-trione
1H-Benzimidazole, 5-(difluoromethoxy)-2-[[(3,4-dimethoxy-2-pyridinyl)methyl]sulfonyl]-
1H-Benzimidazole, 5-(difluoromethoxy)-2-[[(3,4-dimethoxy-2-pyridinyl)methyl]sulfonyl]-
Vitisidin A
7-carboxy-4,11-dihydroxy-3-(4-hydroxy-3,5-dimethoxyphenyl)-2$l^{4},8-dioxatricyclo[7.3.1.0^{5,13}]trideca-1(13),2,4,6,9,11-hexaen-2-ylium
Acetamide, N-(3-acetylphenyl)-2-[(5-ethyl-2,6-dimethylthieno[2,3-d]pyrimidin-4-yl)thio]- (9CI)
Acetamide, N-(3-acetylphenyl)-2-[(5-ethyl-2,6-dimethylthieno[2,3-d]pyrimidin-4-yl)thio]- (9CI)
6-BROMO-2-(3-ISOBUTOXYPHENYL)QUINOLINE-4-CARBOXYLICACID
6-BROMO-2-(3-ISOBUTOXYPHENYL)QUINOLINE-4-CARBOXYLICACID
Rufloxacin hydrochloride
Rufloxacin (hydrochloride)
D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059005 - Topoisomerase II Inhibitors D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D024841 - Fluoroquinolones D004791 - Enzyme Inhibitors
5-(2,4-difluorophenyl)-2-(4-nitrobenzoyl)oxybenzoic acid
5-(2,4-difluorophenyl)-2-(4-nitrobenzoyl)oxybenzoic acid
Methyl 2-(4-(2-(trifluoromethyl)benzoyl)piperazin-1-yl)thiazole-5-carboxylate
Methyl 2-(4-(2-(trifluoromethyl)benzoyl)piperazin-1-yl)thiazole-5-carboxylate
Methyl 5-N,4-O-Carbonyl-3,5-dideoxy-2-S-phenyl-2-thio-D-glycero-beta-D-galacto-2-nonulopyranosylonate
Methyl 5-N,4-O-Carbonyl-3,5-dideoxy-2-S-phenyl-2-thio-D-glycero-beta-D-galacto-2-nonulopyranosylonate
4-(2,4-dichlorophenyl)-8-(trifluoromethoxy)-3a,4,5,9b-tetrahydro-3H-cyclopenta[c]quinoline
4-(2,4-dichlorophenyl)-8-(trifluoromethoxy)-3a,4,5,9b-tetrahydro-3H-cyclopenta[c]quinoline
1-ethyl-2-methylnaphtho[1,2-d]thiazolium toluene-p-sulphonate
1-ethyl-2-methylnaphtho[1,2-d]thiazolium toluene-p-sulphonate
2,6-difluoro-N-(1-{[2-fluoro-6-(trifluoromethyl)phenyl]methyl}-1H-pyrazol-3-yl)benzamide
2,6-difluoro-N-(1-{[2-fluoro-6-(trifluoromethyl)phenyl]methyl}-1H-pyrazol-3-yl)benzamide
4-Nitrobenzoic acid [6-[[(4-methyl-2-pyrimidinyl)thio]methyl]-4-oxo-3-pyranyl] ester
4-Nitrobenzoic acid [6-[[(4-methyl-2-pyrimidinyl)thio]methyl]-4-oxo-3-pyranyl] ester
[2-[[2-[(Dimethylamino)methyl]phenyl]thio]-5-iodophenyl]methanol
[2-[[2-[(Dimethylamino)methyl]phenyl]thio]-5-iodophenyl]methanol
1-[[2-(2,4-Dichlorophenoxy)-1-oxoethyl]amino]-3-(4-methoxyphenyl)thiourea
1-[[2-(2,4-Dichlorophenoxy)-1-oxoethyl]amino]-3-(4-methoxyphenyl)thiourea
ethyl 2-[(4E)-1-acetyl-5-oxo-4-[[4-(1,2,4-triazol-1-yl)phenyl]methylidene]imidazol-2-yl]sulfanylacetate
ethyl 2-[(4E)-1-acetyl-5-oxo-4-[[4-(1,2,4-triazol-1-yl)phenyl]methylidene]imidazol-2-yl]sulfanylacetate
4-Methyl-3-nitrobenzoic acid [4-oxo-6-[(2-pyrimidinylthio)methyl]-3-pyranyl] ester
4-Methyl-3-nitrobenzoic acid [4-oxo-6-[(2-pyrimidinylthio)methyl]-3-pyranyl] ester
4-(4-chlorophenyl)sulfonyl-N-(furan-2-ylmethyl)piperazine-1-carbothioamide
4-(4-chlorophenyl)sulfonyl-N-(furan-2-ylmethyl)piperazine-1-carbothioamide
(4-Bromophenyl)[4-({(2E)-4-[cyclopropyl(methyl)amino]but-2-enyl}oxy)phenyl]methanone
(4-Bromophenyl)[4-({(2E)-4-[cyclopropyl(methyl)amino]but-2-enyl}oxy)phenyl]methanone
(1R)-1-{[(4-Methoxy-1,1-biphenyl-4-YL)sulfonyl]amino}-2-methylpropylphosphonic acid
(1R)-1-{[(4-Methoxy-1,1-biphenyl-4-YL)sulfonyl]amino}-2-methylpropylphosphonic acid
(1S)-1-{[(4-Methoxy-1,1-biphenyl-4-YL)sulfonyl]amino}-2-methylpropylphosphonic acid
(1S)-1-{[(4-Methoxy-1,1-biphenyl-4-YL)sulfonyl]amino}-2-methylpropylphosphonic acid
8-bromo-1-[[4-(trifluoromethyl)phenyl]methyl]-5H-4,1-benzoxazepin-2-one
8-bromo-1-[[4-(trifluoromethyl)phenyl]methyl]-5H-4,1-benzoxazepin-2-one
(1R,2R)-cyclohexane-1,2-diamine;oxalic acid;platinum(2+)
(1R,2R)-cyclohexane-1,2-diamine;oxalic acid;platinum(2+)
D000970 - Antineoplastic Agents
N-[(R)-4-phosphonatopantothenoyl]-L-cysteinate(3-)
N-[(R)-4-phosphonatopantothenoyl]-L-cysteinate(3-)
COVID info from COVID-19 Disease Map Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
2-[(2S,3S)-2,4,6,8-tetrahydroxy-5,10-dioxo-5,10-dihydroanthra[2,3-b]furan-3-yl]ethyl acetate
2-[(2S,3S)-2,4,6,8-tetrahydroxy-5,10-dioxo-5,10-dihydroanthra[2,3-b]furan-3-yl]ethyl acetate
N-[[1-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyindol-3-yl]methyl]carbamodithioate
N-[[1-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyindol-3-yl]methyl]carbamodithioate
(2S)-2-amino-5-[[(2R)-3-[carboxy(chloro)methyl]sulfanyl-1-(carboxymethylamino)-1-oxopropan-2-yl]amino]-5-oxopentanoic acid
(2S)-2-amino-5-[[(2R)-3-[carboxy(chloro)methyl]sulfanyl-1-(carboxymethylamino)-1-oxopropan-2-yl]amino]-5-oxopentanoic acid
Timepidium bromide
Timepidium bromide
A - Alimentary tract and metabolism > A03 - Drugs for functional gastrointestinal disorders > A03A - Drugs for functional gastrointestinal disorders > A03AB - Synthetic anticholinergics, quaternary ammonium compounds C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent
3-[(2,5-dichlorophenoxy)methyl]-N-(2,6-dimethylphenyl)benzamide
3-[(2,5-dichlorophenoxy)methyl]-N-(2,6-dimethylphenyl)benzamide
Ethyl 2-[(4-bromo-1-ethylpyrazole-3-carbonyl)amino]-4,5-dimethylthiophene-3-carboxylate
Ethyl 2-[(4-bromo-1-ethylpyrazole-3-carbonyl)amino]-4,5-dimethylthiophene-3-carboxylate
N-(6-ethoxy-1,3-benzothiazol-2-yl)-2-[(3-methyl-2-imidazo[4,5-b]pyridinyl)thio]acetamide
N-(6-ethoxy-1,3-benzothiazol-2-yl)-2-[(3-methyl-2-imidazo[4,5-b]pyridinyl)thio]acetamide
(2S,3S)-versiconal hemiacetal acetate(1-)
(2S,3S)-versiconal hemiacetal acetate(1-)
A phenolate anion obtained by deprotonation of the 8-hydroxy group of (2S-3S)-versiconal hemiacetal acetate. It is the major microspecies at pH 7.3 (according to Marvin v 6.2.0.).
2-chloro-N-[5-chloro-2-(4-methyl-1-piperazinyl)phenyl]benzenesulfonamide
2-chloro-N-[5-chloro-2-(4-methyl-1-piperazinyl)phenyl]benzenesulfonamide
2-[(4-fluoro-2-methylphenyl)sulfonylamino]-N-(3-pyridinylmethyl)benzamide
2-[(4-fluoro-2-methylphenyl)sulfonylamino]-N-(3-pyridinylmethyl)benzamide
2,4-difluoro-N-[4-(1,1,1,3,3,3-hexafluoro-2-hydroxypropan-2-yl)phenyl]benzamide
2,4-difluoro-N-[4-(1,1,1,3,3,3-hexafluoro-2-hydroxypropan-2-yl)phenyl]benzamide
4-[[[5-[(4-chlorophenoxy)methyl]-1,3,4-oxadiazol-2-yl]thio]methyl]-1H-quinolin-2-one
4-[[[5-[(4-chlorophenoxy)methyl]-1,3,4-oxadiazol-2-yl]thio]methyl]-1H-quinolin-2-one
2-(2-Chloro-6-fluoro-phenyl)-3-(4-methyl-6-phenyl-pyrimidin-2-yl)thiazolidin-4-one
2-(2-Chloro-6-fluoro-phenyl)-3-(4-methyl-6-phenyl-pyrimidin-2-yl)thiazolidin-4-one
2,6-difluoro-N-[4-(1,1,1,3,3,3-hexafluoro-2-hydroxypropan-2-yl)phenyl]benzamide
2,6-difluoro-N-[4-(1,1,1,3,3,3-hexafluoro-2-hydroxypropan-2-yl)phenyl]benzamide
2-[(2-cyclopropyl-5,6,7,8-tetrahydro-[1]benzothiolo[2,3-d]pyrimidin-4-yl)thio]-N-(2-furanylmethyl)acetamide
2-[(2-cyclopropyl-5,6,7,8-tetrahydro-[1]benzothiolo[2,3-d]pyrimidin-4-yl)thio]-N-(2-furanylmethyl)acetamide
2-Acetyl-3,4a,8,10,11,12a-hexahydroxy-1,4,4a,5,12,12a-hexahydrotetracene-1,12-dione
2-Acetyl-3,4a,8,10,11,12a-hexahydroxy-1,4,4a,5,12,12a-hexahydrotetracene-1,12-dione
(4-Chlorophenyl)-[4-(7-chloro-4-quinolinyl)-2-methyl-1-piperazinyl]methanone
(4-Chlorophenyl)-[4-(7-chloro-4-quinolinyl)-2-methyl-1-piperazinyl]methanone
N-[(E)-(2-bromo-5-methoxyphenyl)methylideneamino]-N-hydroxyoctanediamide
N-[(E)-(2-bromo-5-methoxyphenyl)methylideneamino]-N-hydroxyoctanediamide
Ethyl 3-[(2-chlorophenyl)diazenyl]-2-methyl-4,5-dioxo-1-phenylpyrrolidine-2-carboxylate
Ethyl 3-[(2-chlorophenyl)diazenyl]-2-methyl-4,5-dioxo-1-phenylpyrrolidine-2-carboxylate
4-chloro-N-(4,5-dihydroxy-2-methyl-2,3,4,5-tetrahydroindol-1-yl)-3-sulfamoylbenzamide
4-chloro-N-(4,5-dihydroxy-2-methyl-2,3,4,5-tetrahydroindol-1-yl)-3-sulfamoylbenzamide
[5-[2-amino-5-(formamidomethyl)-4-oxo-3H-pyrrolo[2,3-d]pyrimidin-7-yl]-3-hydroxy-2,5-dihydrofuran-2-yl]methyl phosphate
[5-[2-amino-5-(formamidomethyl)-4-oxo-3H-pyrrolo[2,3-d]pyrimidin-7-yl]-3-hydroxy-2,5-dihydrofuran-2-yl]methyl phosphate
(2R)-{(3S)-3-[(2Z)-2-(hydroxyimino)-2-(4-hydroxyphenyl)acetamido]-2-oxoazetidin-1-yl}(4-hydroxyphenyl)acetic acid
(2R)-{(3S)-3-[(2Z)-2-(hydroxyimino)-2-(4-hydroxyphenyl)acetamido]-2-oxoazetidin-1-yl}(4-hydroxyphenyl)acetic acid
N-[(R)-4-phosphonatopantothenoyl]-L-cysteinate(3-)
N-[(R)-4-phosphonatopantothenoyl]-L-cysteinate(3-)
Trianion of N-[(R)-4-phosphopantothenoyl]-L-cysteine arising from deprotonation of carboxylic acid and phosphate functions.
NS3861 (fumarate)
NS3861 (fumarate)
NS3861 fumarate is an agonist of nicotinic acetylcholine receptors (nAChRs) and binds with high affinity to heteromeric α3β4 nAChR. The binding Ki values of 0.62, 25, 7.8, 55 nM for α3β4, α3β2, α4β4, α4β2, respectively[1].
(2r)-1-({5,6-dihydroxy-2-methyl-4,8,9-trioxocyclohexa[g]chromen-7-yl}methyl)pyrrolidine-2-carboxylic acid
(2r)-1-({5,6-dihydroxy-2-methyl-4,8,9-trioxocyclohexa[g]chromen-7-yl}methyl)pyrrolidine-2-carboxylic acid
3-{[3-({3-[(4-hydroxyphenyl)methanethioamido]-1-sulfanylpropylidene}amino)-1-sulfanylpropylidene]amino}propanoic acid
3-{[3-({3-[(4-hydroxyphenyl)methanethioamido]-1-sulfanylpropylidene}amino)-1-sulfanylpropylidene]amino}propanoic acid
(2s)-2-amino-4-{[(1r)-2-({[(r)-(2r)-2-amino-2-carboxyethanesulfinyl]methyl}sulfanyl)-1-carboxyethyl]-c-hydroxycarbonimidoyl}butanoic acid
(2s)-2-amino-4-{[(1r)-2-({[(r)-(2r)-2-amino-2-carboxyethanesulfinyl]methyl}sulfanyl)-1-carboxyethyl]-c-hydroxycarbonimidoyl}butanoic acid
(2s)-2-{[hydroxy(4,5,7-trihydroxy-9,10-dioxoanthracen-2-yl)methylidene]amino}-3-methylbutanoic acid
(2s)-2-{[hydroxy(4,5,7-trihydroxy-9,10-dioxoanthracen-2-yl)methylidene]amino}-3-methylbutanoic acid
2-amino-4-[(2-{[(2-amino-2-carboxyethanesulfinyl)methyl]sulfanyl}-1-carboxyethyl)-c-hydroxycarbonimidoyl]butanoic acid
2-amino-4-[(2-{[(2-amino-2-carboxyethanesulfinyl)methyl]sulfanyl}-1-carboxyethyl)-c-hydroxycarbonimidoyl]butanoic acid
(2s)-2-{[(1s)-3-{[(2r)-2-amino-2-carboxyethyl]selanyl}-1-carboxypropyl]amino}-4-(c-hydroxycarbonimidoyl)butanoic acid
(2s)-2-{[(1s)-3-{[(2r)-2-amino-2-carboxyethyl]selanyl}-1-carboxypropyl]amino}-4-(c-hydroxycarbonimidoyl)butanoic acid
(2s)-2-{[(1r)-2-{[(3s)-3-amino-3-carboxypropyl]selanyl}-1-carboxyethyl]amino}-4-(c-hydroxycarbonimidoyl)butanoic acid
(2s)-2-{[(1r)-2-{[(3s)-3-amino-3-carboxypropyl]selanyl}-1-carboxyethyl]amino}-4-(c-hydroxycarbonimidoyl)butanoic acid
(2s,5s)-5-[2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4-oxochromen-6-yl]pyrrolidine-2-carboxylic acid
(2s,5s)-5-[2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4-oxochromen-6-yl]pyrrolidine-2-carboxylic acid
2-{[hydroxy(4,5,7-trihydroxy-9,10-dioxoanthracen-2-yl)methylidene]amino}-3-methylbutanoic acid
2-{[hydroxy(4,5,7-trihydroxy-9,10-dioxoanthracen-2-yl)methylidene]amino}-3-methylbutanoic acid
2-({3-[(2-amino-2-carboxyethyl)selanyl]-1-carboxypropyl}amino)-4-(c-hydroxycarbonimidoyl)butanoic acid
2-({3-[(2-amino-2-carboxyethyl)selanyl]-1-carboxypropyl}amino)-4-(c-hydroxycarbonimidoyl)butanoic acid
(2s,5r)-5-[2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4-oxochromen-6-yl]pyrrolidine-2-carboxylic acid
(2s,5r)-5-[2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4-oxochromen-6-yl]pyrrolidine-2-carboxylic acid
2-({2-[(3-amino-3-carboxypropyl)selanyl]-1-carboxyethyl}amino)-4-(c-hydroxycarbonimidoyl)butanoic acid
2-({2-[(3-amino-3-carboxypropyl)selanyl]-1-carboxyethyl}amino)-4-(c-hydroxycarbonimidoyl)butanoic acid
3,4-dimethoxy-2-{5-oxo-2h,7h,8h-[1,3]dioxolo[4,5-g]isoquinoline-6-carbonyl}benzoic acid
3,4-dimethoxy-2-{5-oxo-2h,7h,8h-[1,3]dioxolo[4,5-g]isoquinoline-6-carbonyl}benzoic acid
